← FDA Drug Approvals (Drugs@FDA)
ELOXATIN
NDA · New Drug Application · Sponsor: SANOFI AVENTIS US · Approved 2005-01-31
Drug application
- FDA Application #
NDA021759- Application type
- New Drug Application
- Brand name
- ELOXATIN
- Generic name
- OXALIPLATIN
- Active ingredients
- OXALIPLATIN
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Discontinued
- Sponsor
- SANOFI AVENTIS US
- Manufacturer
- Winthrop U.S, a business of sanofi-aventis U.S. LLC
- First approval
- 2005-01-31
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown